APO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Apollo Global Management Inc (APO) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, options sentiment leans negative, and recent news raises concerns about corporate governance. While the company has strong revenue growth, its net income and EPS have significantly declined, and no Intellectia Proprietary Trading Signals are present to suggest an immediate opportunity. It is advisable to hold off on investing until clearer positive catalysts emerge.
The technical indicators for APO are bearish. The MACD histogram is negative and expanding downward, the RSI is neutral at 33.157, and the moving averages show a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot point of 130.915, with key support at 123.999 and resistance at 137.831.
Analysts remain optimistic about Apollo's long-term growth potential, with multiple firms maintaining Buy or Overweight ratings and raising price targets. The company is well-positioned to benefit from mega trends in alternative investments and income solutions for aging populations.
Recent news of a potential securities fraud investigation related to executive discussions with Jeffrey Epstein has raised corporate governance concerns. Additionally, the company's net income and EPS have seen significant YoY declines in the latest quarter, which may deter investor confidence.
In Q4 2025, Apollo's revenue increased significantly by 68.43% YoY to $9.83 billion. However, net income dropped by 53.36% YoY to $660 million, and EPS fell by 52.56% YoY to $1.11. This indicates strong top-line growth but declining profitability.
Analysts maintain a positive long-term outlook on APO, with recent price targets ranging from $158 to $186. Morgan Stanley and Deutsche Bank highlight growth acceleration and strong positioning in alternative investments. However, Barclays and BofA have slightly lowered their price targets, citing market-wide concerns and valuation adjustments.
